5. Chirality and pharmacokinetics
As a general rule, whether we're talking about a racemate, a pure enantiomer or a non-chiral drug, knowledge of pharmacokinetic parameters is essential before any drug can be marketed. Pharmacokinetics enable us to determine absorption rates, binding to plasma proteins, distribution to various tissues, metabolism with or without the formation of one or more metabolites, elimination and half-life, all of which help define the drug's mode of use.
Moreover, since amino acids, carbohydrates, complex lipids and macromolecules in living matter such as plasma proteins, enzymes, membrane and nuclear receptors are asymmetric, interactions with chiral molecules can be enantioselective, leading to different pharmacokinetic parameters for each enantiomer. The same applies to the action of enzymes, which may act differently on each enantiomer, leading to the formation of different...
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Chirality and pharmacokinetics
Chirality and Regulatory Affairs
Article included in this offer
"Drugs and pharmaceuticals"
(
125 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
References
- (1) - - Ouvrages et revues traitant des rapports entre la stéréochimie et les propriétés pharmacologiques et pharmacocinétiques de médicaments : WINEFORDER (J.D.). – The impact of stereochemistry on drug development and use. Volume 12. John Wiley and Sons Inc., New York (1997) ; WAINER (I.W.) et DRAYER (D.E.). – Stereochemistry. Analytical methods and pharmacology....
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
